1. Home
  2. KBSX vs CLYM Comparison

KBSX vs CLYM Comparison

Compare KBSX & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KBSX
  • CLYM
  • Stock Information
  • Founded
  • KBSX N/A
  • CLYM 2018
  • Country
  • KBSX Taiwan
  • CLYM United States
  • Employees
  • KBSX N/A
  • CLYM N/A
  • Industry
  • KBSX Recreational Games/Products/Toys
  • CLYM
  • Sector
  • KBSX Consumer Discretionary
  • CLYM
  • Exchange
  • KBSX Nasdaq
  • CLYM NYSE
  • Market Cap
  • KBSX 104.0M
  • CLYM 101.6M
  • IPO Year
  • KBSX N/A
  • CLYM 2021
  • Fundamental
  • Price
  • KBSX $6.78
  • CLYM $1.47
  • Analyst Decision
  • KBSX
  • CLYM
  • Analyst Count
  • KBSX 0
  • CLYM 0
  • Target Price
  • KBSX N/A
  • CLYM N/A
  • AVG Volume (30 Days)
  • KBSX 9.4K
  • CLYM 331.6K
  • Earning Date
  • KBSX 04-25-2025
  • CLYM 03-27-2025
  • Dividend Yield
  • KBSX N/A
  • CLYM N/A
  • EPS Growth
  • KBSX N/A
  • CLYM N/A
  • EPS
  • KBSX N/A
  • CLYM N/A
  • Revenue
  • KBSX $33,935,076.00
  • CLYM N/A
  • Revenue This Year
  • KBSX N/A
  • CLYM N/A
  • Revenue Next Year
  • KBSX N/A
  • CLYM N/A
  • P/E Ratio
  • KBSX N/A
  • CLYM N/A
  • Revenue Growth
  • KBSX N/A
  • CLYM N/A
  • 52 Week Low
  • KBSX $5.24
  • CLYM $1.41
  • 52 Week High
  • KBSX $15.48
  • CLYM $11.55
  • Technical
  • Relative Strength Index (RSI)
  • KBSX N/A
  • CLYM N/A
  • Support Level
  • KBSX N/A
  • CLYM N/A
  • Resistance Level
  • KBSX N/A
  • CLYM N/A
  • Average True Range (ATR)
  • KBSX 0.00
  • CLYM 0.00
  • MACD
  • KBSX 0.00
  • CLYM 0.00
  • Stochastic Oscillator
  • KBSX 0.00
  • CLYM 0.00

About CLYM CLIMB BIO INC

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.

Share on Social Networks: